Standard Biotools Inc traded at $1.81 this Wednesday August 17th, decreasing $0.15 or 7.65 percent since the previous trading session. Looking back, over the last four weeks, Standard Biotools Inc lost 23.13 percent. Over the last 12 months, its price fell by 72.28 percent. Looking ahead, we forecast Standard Biotools Inc to be priced at 1.71 by the end of this quarter and at 1.57 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Sony 11,750.00 -210.00 -1.76% 10.80%
Nikon Corporation 1,588.00 -14.00 -0.87% 46.49%
Agilent 142.29 9.52 7.17% -12.72%
Becton, Dickinson and Co. 264.23 -3.55 -1.33% 6.60%
Bio-Rad Laboratories 524.11 -9.86 -1.85% -32.00%
Bruker 61.43 0.68 1.12% -25.91%
Danaher 297.27 -3.21 -1.07% -7.04%
Standard Biotools Inc 1.81 -0.15 -7.65% -72.28%
Illumina 213.02 -6.81 -3.10% -58.28%
Myriad Genetics 25.53 -1.38 -5.13% -22.31%
NanoString Technologies 14.63 -0.88 -5.67% -71.25%
Pacific Biosciences Of California 7.61 -0.39 -4.88% -71.57%
PerkinElmer 150.74 -5.56 -3.56% -16.75%
Roche Holding 316.65 1.00 0.32% -15.00%
Thermo Fisher Scientific 596.04 -6.07 -1.01% 8.00%
Waters 335.42 6.22 1.89% -16.30%

Indexes Price Day Year
USND 12938 -164.43 -1.25% -10.93%
US2000 1987 -33.22 -1.64% -7.94%

Standard Biotools Inc
Fluidigm Corporation creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents, and software that are used by researchers and clinical labs. The Company operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. It markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.